Peginterferon Alfa: Clinical Trials

6 trials of Peginterferon Alfa, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown, 1 completed. 5 Phase 4, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 45Unknown 5
Phase 11Completed 1

Follow Peginterferon Alfa: new trials by email Literature Review of Peginterferon Alfa trials Research Report on Peginterferon Alfa

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Optimizing Treatment of Peginterferon Alpha in Chronic Hepatitis B Patients With Low Level HBsAg
Peginterferon Alfa, Nucleoside Analog (Substance) - Chronic Hepatitis B
Phase 4UnknownThird Affiliated Hospital, Sun Yat-Sen University2002019-01-012019-01-15
The Optimizing Treatment of Peginterferon (PEG IFN) Alpha in Chronic Hepatitis B Virus Patients With Low Level HBsAg
peginterferon alfa - Chronic Hepatitis B
Phase 4UnknownThird Affiliated Hospital, Sun Yat-Sen University2002016-08-012018-05-22
HBsAg Loss/Seroconversion in Low Replicative Chronic Hepatitis B Virus(HBV) Infection Patients
peginterferon alfa - Chronic Hepatitis B
Phase 4UnknownThird Affiliated Hospital, Sun Yat-Sen University2002016-08-012018-05-22
The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAg
peginterferon alfa, Nucleoside analogues - Chronic Hepatitis B
Phase 4UnknownThird Affiliated Hospital, Sun Yat-Sen University2002016-06-012019-01-15
The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAg
Peginterferon alfa - Chronic Hepatitis B
Phase 4UnknownThird Affiliated Hospital, Sun Yat-Sen University2002016-04-012019-01-15
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Assessment of Ypeginterferon Alfa-2a in Healthy Subjects
Peginterferon alfa, Peginterferon alfa 2a, Peginterferon alfa-2a - Healthy Subjects
Phase 1CompletedXiamen Amoytop Biotech Co., Ltd.392011-01-012012-01-31

Conditions studied

Hepatitis B, Chronic (5)

Sponsors

Third Affiliated Hospital, Sun Yat-Sen University (5)  ·  Xiamen Amoytop Biotech Co., Ltd. (1)

Countries

China (6)

Top investigators

Wei Zhenman, Ph.D (1)  ·  Zhiliang Gao (1)  ·  Zhiliang Gao, Doctor (1)